Articles

10.4244/EIJV8I1A13 May 15, 2012
Coronary perforation in the drug-eluting stent era: incidence, risk factors, management and outcome: the UK experience
Hendry C, Fraser D, Eichhöfer J, Mamas MA, Fath-Ordoubadi F, El-Omar M, Williams P
free

10.4244/EIJV8I1A14 May 15, 2012
Impact of age on clinical outcomes after everolimus-eluting and paclitaxel-eluting stent implantation: pooled analysis from the SPIRIT III and SPIRIT IV clinical trials
Hermiller J, Sudhir K, Applegate R, Rizvi A, Wang J, Gordon P, Yaqub M, Cao S, Ferguson J, Smith R, Sood P, MPhil M, Stone GW
free

10.4244/EIJV8I1A15 May 15, 2012
Percutaneous closure of atrial right-to-left shunt in patients with Ebstein’s anomaly of the tricuspid valve
Silva M, Teixeira A, Menezes I, Nogueira G, Ferreira R, Maymone-Martins F, Anjos R
free

10.4244/EIJV8I1A16 May 15, 2012
Offline fusion of co-registered intravascular ultrasound and frequency domain optical coherence tomography images for the analysis of human atherosclerotic plaques
Räber L, Heo J, Radu M, Garcia-Garcia H, Stefanini G, Moschovitis A, Dijkstra J, Kelbæk H, Windecker S, Serruys PW
free

10.4244/EIJV8I1A17 May 15, 2012
Clinical performance of a drug-eluting stent with a biodegradable polymer in an unselected patient population: the NOBORI 2 study
Danzi G, Chevalier B, Urban P, Fath-Ordoubadi F, Carrié D, Wiemer M, Serra A, Wijns W, Kala P, Stabile A, Ruigomez J, Sagic D, Laanmets P, Strupp G, West N, Paunovic D
free

10.4244/EIJV8I1A18 May 15, 2012
Late clinical outcomes after implantation of drug-eluting stents coated with biodegradable polymers: 3-year follow-up of the PAINT randomised trial
Lemos P, Moulin B, Perin M, Oliveira L, Arruda J, Lima V, Lima A, Caramori P, Medeiros C, Barbosa M, Brito F, Ribeiro E
free

10.4244/EIJV8I1A19 May 15, 2012
Virtual and real bench testing of a new percutaneous valve device: a case study
Biglino G, Capelli C, Binazzi A, Reggiani R, Cosentino D, Migliavacca F, Bonhoeffer P, Taylor A, Schievano S
free

10.4244/EIJV8I1A20 May 15, 2012
Risk of stroke after transcatheter aortic valve implantation (TAVI): a meta-analysis of 10,037 published patients
Eggebrecht H, Schmermund A, Voigtl T, Kahlert P, Erbel R, Mehta R
free

10.4244/EIJV8I1A21 May 15, 2012
Recanalisation of Chronic Total coronary Occlusions: 2012 consensus document from the EuroCTO club
Sianos G, Werner G, Galassi A, Papafaklis M, Escaned J, Hildick-Smith D, Christiansen E, Gershlick A, Carlino M, Karlas A, Konstantinidis N, Tomasello S, Di Mario C, Reifart N
free

10.4244/EIJV8I1A22 May 15, 2012
Improving informed consent in percutaneous coronary revascularisation
Bromage D, Lim J, ter Meulen R, Ramcharitar S
free

10.4244/EIJV8I1A23 May 15, 2012
How should I treat guidewire-induced distal coronary perforation?
Senguttuvan N, Ramakrishnan S, Gulati G, Seth S, Bhargava B
free

10.4244/EIJV8I1A24 May 15, 2012
Tools & Techniques: The year of the textbook – time to say good-bye!
Naber CK, Sachdev B, Muller O, Eeckhout E, Fajadet J
free

10.4244/EIJV8I1A25 May 15, 2012
Coronary artery perforation imaged through 3-dimensional optical coherence tomography
Porto I, Di Vito L, Prati F, Crea F
free

10.4244/EIJV8I1A26 May 15, 2012
Brain malignancies and ionising radiation: more cases reported
Roguin A, Goldstein J, Bar O
free

10.4244/EIJV8I1A27 May 15, 2012
Reflections after reading “A shrinking world?”
Iosseliani D
free
Receive our newsletter


The Official Journal of EuroPCR and the European Association of Percutaneous Cardiovascular Interventions (EAPCI)

EuroPCR EAPCI
PCR ESC
Impact factor: 7.6
2023 Journal Citation Reports®
Science Edition (Clarivate Analytics, 2024)
Online ISSN 1969-6213 - Print ISSN 1774-024X
© 2005-2025 Europa Group - All rights reserved